Home - Products - Others - Other Targets - 1,3-Dihydroxy-2,7,8-trimethoxy-6-methyl-9,10-anthracenedione

1,3-Dihydroxy-2,7,8-trimethoxy-6-methyl-9,10-anthracenedione

CAS No. 1622982-59-5

1,3-Dihydroxy-2,7,8-trimethoxy-6-methyl-9,10-anthracenedione( ——— )

Catalog No. M38226 CAS No. 1622982-59-5

6,8-Dihydroxy-1,2,7-trimethoxy-3-methylanthraquinone (compound 1) is an anthraquinone α-glucosidase inhibitor (IC50:185 μM), which can be isolated from Cassia seeds.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
25MG Get Quote Get Quote
50MG Get Quote Get Quote
100MG Get Quote Get Quote
200MG Get Quote Get Quote
500MG Get Quote Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    1,3-Dihydroxy-2,7,8-trimethoxy-6-methyl-9,10-anthracenedione
  • Note
    Research use only, not for human use.
  • Brief Description
    6,8-Dihydroxy-1,2,7-trimethoxy-3-methylanthraquinone (compound 1) is an anthraquinone α-glucosidase inhibitor (IC50:185 μM), which can be isolated from Cassia seeds.
  • Description
    6,8-Dihydroxy-1,2,7-trimethoxy-3-methylanthraquinone (compound 1) is an anthraquinone α-glucosidase inhibitor (IC50:185 μM), which can be isolated from Cassia seeds.
  • In Vitro
    ———
  • In Vivo
    ———
  • Synonyms
    ———
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    IC50: 185 μM (α-Glucosidase)
  • Research Area
    ———
  • Indication
    ———

Chemical Information

  • CAS Number
    1622982-59-5
  • Formula Weight
    344.32
  • Molecular Formula
    C18H16O7
  • Purity
    >98% (HPLC)
  • Solubility
    ———
  • SMILES
    ———
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Xu YL, et al. Five new anthraquinones from the seed of Cassia obtusifolia. Arch Pharm Res. 2015 Jun;38(6):1054-8.?
molnova catalog
related products
  • 1-Hydroxybaccatin I

    1-Hydroxybaccatin I possesses significant antinociceptive activity against p- benzoquinone-induced abdominal contractions.

  • Naratuximab

    Naratuximab emtansine is a humanized monoclonal antibody (Anti-TSPAN26/CD37 Reference Antibody (naratuximab)) that specifically targets CD37 (TSPAN26) and serves as the basis for creating an antibody-drug conjugate (ADC) compound.

  • Clozic

    Clozic exhibits reversible anti-proliferative effects and can be used in studies about serving as a potential anti-arthritic agent.